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Regulation of vascular tone and the 
endothelium
Since the early 20th century, physiologists 
have been interested in skeletal muscle blood 
flow regulation, particularly during occasions 
of stress to the body, such as muscle 
contraction (exercise) or changes in 
gravitational force (standing). Eventually it 
was realized the endothelium, a monolayer of 
epithelial cells separating the lumen of the 
vessel from the smooth muscle cells, was an 
important mediator of vascular tone and 
capable of releasing factors that elicited 
vasodilatation. Robert F. Furchgott first posed 
the idea of an ‘endothelium-derived relaxing 
factor’ (EDRF) (Furchgott & Zawadzki, 1980), 
later identified by Furchgott and Louis J. 
Ignarro as the gaseous nitric oxide (NO).
In 1998, a Nobel Prize was awarded for the 
discoveries concerning NO as a cardiovascular 
signalling molecule. We and others were aware 
of the potential relationship between NO and 
cardiovascular health, particularly as it related 
to ageing. Initially, we focused on the impact 
of age and regular aerobic exercise training on 
large artery structure and function, conduit 
and resistance vessel endothelial function, and 
peripheral blood flow under resting conditions. 
Many of these studies did not address NO 
specifically; however, bioavailability of this 
molecule, either attenuated with age or 
improved with exercise, was a proposed 
mechanism to a number of our observations.
Eventually, we used intra-arterial pharmacology 
to address mechanisms of local regulation of 
vascular tone and performed a variety of 
studies, many to determine the role of NO by 
utilizing exogenous L-arginine analogues (the 
precursor for endothelial nitric oxide synthase 
(NOS)-derived NO) to inhibit NO synthesis. 
We also possessed the ability to directly 
stimulate and inhibit the action of the 
sympathetic nervous system with specific 
receptor agonist and antagonists, fuelling our 
rapid growth of understanding how the nervous 
system influences skeletal muscle blood flow.
As the new millennium was ushered in, the 
phenomenon of ‘functional sympatholysis’ (see 
box), first proposed by Remensmyder in the 
early 1960s (Remensnyder et al. 1962), was 
observable in both human and animal studies in 
a variety of preparations. Regarding underlying 
mechanisms of this response, Thomas and 
colleagues demonstrated that functional 
sympatholysis in the contracting rat hindlimb 
was impaired in the presence of NOS inhibition 
(Thomas & Victor, 1998). However, when we 
attempted to translate these findings of a 
significant role for NO in functional 
sympatholysis to our human studies, we were 
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While it is satisfying to be ‘right’ as scientists, we know sometimes the 
most important progress occurs when data are surprising or contrary to 
our original hypothesis. The pursuit of explanations for unexpected findings 
often leads to the best advancements. The story of how our laboratory 
came to investigate the underlying vasodilator pathways of adenosine 
triphosphate (ATP) (Crecelius et al. 2012) is an example of such a path to 
our current understanding.
Our hyper-polarizing story:  
understanding ATP-mediated vasodilatation in humans 
Negative results, cynicism, the piecing together of puzzles and integrating 
physiology with experimental approaches. It’s all part of the inspiring and 
meandering journey on the path to understand ATP-mediated vasodilatation.
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unable to do so. We took a variety of 
approaches, but continually failed to observe a 
significant ability for NO to blunt sympathetically 
mediated vasoconstriction when given directly 
as sodium nitroprusside, as well as observed 
intact functional sympatholysis in the presence 
of NOS inhibition (Dinenno & Joyner, 2003). 
Additionally, NO did not appear to be obligatory 
for vasodilatation during muscle contractions 
and combined inhibition of NO and other 
endothelial-derived vasodilators such as 
prostaglandins (PGs) resulted in a modest 
decline (~25%) in exercise hyperaemia when 
inhibition occurred during muscle contractions 
(Schrage et al. 2004). Taken together, while 
evidence was strong for the vasoprotective 
properties of NO in humans, data from our 
laboratory and others indicated that vascular 
regulation during muscle contractions 
appeared to be somewhat independent of this 
endothelial-derived vasorelaxant.
Interestingly, the lack of an obligatory role for 
NO in both exercise hyperaemia and functional 
sympatholysis in humans was somewhat 
perplexing given our findings demonstrating 
impaired vasodilatation and functional 
sympatholysis in healthy, sedentary older 
individuals during exercise, a group well-
characterized by decreased NO bioavailability 
(Kirby et al. 2010, 2011). Had we observed 
that NO was obligatory in these cases, a 
logical theory of impaired blood flow control 
during exercise in older adults would have 
existed. This was not the case, and it would 
take us several more years of both basic science 
and clinical studies before we formed an overall 
hypothesis for what molecule other than NO 
might explain these collective findings.
Extracellular ATP: unique vascular 
capabilities
Early studies appreciated the diverse function 
of purines in cardiovascular regulation, but it 
was not until the late 1990s that investigators 
began to develop a hypothesis regarding the 
role of erythrocyte-released extracellular ATP 
as a mediator of the matching of muscle 
perfusion to oxygen demand (Ellsworth et al. 
2009). Building upon this idea, in 2004 
Rosenmeier and colleagues demonstrated that 
circulating ATP was capable of overriding 
sympathetic vasoconstriction in the leg 
evoked by the infusion of tyramine, a drug 
that elicits endogenous noradrenaline (NA) 
release (Fig. 1) (Rosenmeier et al. 2004). The 
finding of an exogenous substance capable of 
being ‘sympatholytic’ was rather surprising as 
over the years we had tested many 
substances in this regard, none of which 
mimicked what occurred in contracting 
skeletal muscle.
What is ‘functional 
sympatholysis’? 
• Activation of the sympathetic 
nervous system elicits 
vasoconstriction via noradrenaline 
(NA) binding to post-junctional 
α-adrenergic receptors on vascular 
smooth muscle cells.
• Functional sympatholysis describes 
the ability of muscle contractions 
to blunt the magnitude of   
vasoconstriction that a given 
sympathetic stimulus elicits, 
relative to what occurs in inactive 
tissue.
• This mechanism of vascular control 
during exercise is thought to allow 
for a balance between increased 
local blood flow and therefore 
oxygen delivery to active tissue, 
while the ability to cause some 
sympathetically mediated 
vasoconstriction can occur to 
prevent unopposed declines in 
systemic resistance and therefore 
maintain mean arterial blood 
pressure.
Figure 1. ATP is sympatholytic in the human leg. In young healthy humans, leg blood flow 
was measured at rest, during a hyperaemic steady-state and with femoral artery infusion of 
tyramine to elicit endogenous noradrenaline release and therefore sympathetically mediated 
vasoconstriction. Adenosine (cross-hatched bar) is used to cause significant vasodilatation 
and increase blood flow to inactive tissue. Tyramine infusion results in significant 
sympathetically mediated vasoconstriction during adenosine infusion but not during exogenous 
ATP infusion (filled bars) or single leg-extension exercise (hatched bars). Data are means ± 
SEM for 8 subjects. *P < 0.05 vs. high flow; †P < 0.05 vs. both combined ATP and tyramine 
and exercise and tyramine. Modified from Rosenmeier et al. (2004) with permission.
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Figure 2.
Figure 2. Summary of endothelial-derived hyperpolarization and pharmacological inhibition of inwardly rectifying potassium 
channels (KIR) and Na+/K+-ATPase. ATP binds to purinergic type 2 receptors (P2R) causing endothelial intracellular [Ca2+] to 
increase, stimulating calcium-activated potassium channels of small (sKCa) and intermediate (iKCa) conductance as well as 
hyperpolarization of endothelial cells. K+ efflux from the KCa channels stimulates inwardly rectifying potassium (KIR) channels and 
the Na+/K+-ATPase pump, both of which lead to membrane potential hyperpolarization and relaxation of the vascular smooth 
muscle cells (VSMCs). Barium chloride (BaCl2) and ouabain can be used to inhibit KIR channels and Na+/K+-ATPase, respectively. KIR 
channels are also activated directly by VSMC hyperpolarization and are thus thought to contribute to the amplification (Jantzi et 
al. 2006) and spread of hyperpolarizing stimuli throughout the VSMC. VGCC, voltage-gated Ca2+ channel.
Figure 3. ATP-mediated 
vasodilatation occurs through 
activation of KIR channels. In young 
healthy humans, forearm blood flow 
was determined and forearm 
vascular conductance (FVC) was 
calculated (index of vascular tone) 
at rest and during increasing doses 
of exogenous ATP infusions 
(brachial artery) in control 
conditions (filled bars) and with 
coinfusion of BaCl2 (cross-hatched 
bars) to inhibit KIR channel 
activation. The increase in FVC was 
attenuated ~50% at both doses of 
ATP. Data are means ± SEM for 6 
subjects. *P < 0.05 vs. Control. 
Modified from Crecelius et al. 
(2012).
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In truth, we were quite sceptical of these 
intriguing findings, and thus we designed a 
study in the forearm to confirm ATP was 
capable of overriding sympathetically 
mediated vasoconstriction and specifically 
address whether this occurred post-
junctionally, as is the case during muscle 
contractions. The synaptic level of modulation 
was unable to be determined from the findings 
of Rosenmeier and colleagues given their 
experimental approach of tyramine-induced 
vasoconstriction. To our surprise, we built 
upon the results from the Scandinavian group 
and showed ATP is clearly capable of post-
junctional modulation of sympathetically 
mediated vasoconstriction and importantly, 
that this occurs in a graded manner such that 
a low dose of exogenous ATP is not 
sympatholytic, whereas higher doses are 
(Kirby et al. 2008). The graded nature of the 
sympatholytic ability of ATP parallels the 
graded effect of exercise intensity on 
functional sympatholysis. We were then 
convinced that in addition to being a potent 
vasodilator, ATP possesses unique signalling 
properties that merit additional study.
At this time our interest in ageing began to 
merge with our developing knowledge of 
vasoactive ATP. Animal-based experiments 
indicated that ATP-mediated vasodilatation 
was dependent on an intact endothelium and 
this led us to pursue whether ATP could be 
used as a test of endothelial function in older 
adults, similar to how the muscarinic agonist 
acetylcholine was used by our group and 
others. However, contrary to our hypothesis, 
ATP-mediated vasodilatation was not impaired 
in older individuals, despite these subjects 
demonstrating ‘endothelial dysfunction’ as 
characterized by impaired dilator responses to 
acetylcholine (Kirby et al. 2010). This 
‘incorrect’ hypothesis would be critical in the 
development of our future research that tried 
to explain this unanticipated finding. Firstly, 
what endothelial-derived vasodilators was ATP 
stimulating? Secondly, whatever this 
mechanism might be, could it lend important 
insight into the unexplained aspects of 
vascular regulation during exercise?
Several lines of evidence suggested that what 
was termed ‘endothelial dysfunction’ at that 
point could be more specifically termed 
‘decreased NO bioavailability’. Given ATP 
seemed to be dissociated from NO 
bioavailability based on our dilatory study in 
older adults (Kirby et al. 2010) and the 
studies on sympatholysis in younger adults 
(Kirby et al. 2008), we pursued what 
vasodilator pathways were stimulated by 
exogenous ATP. Initially, we investigated the 
role of the endothelial-derived vasodilators 
NO and PGs, as the existing literature was 
equivocal in this regard. No matter the manner 
in which we tested the idea, at varied doses 
and timing of inhibition and multiple 
measurement techniques of muscle blood 
flow, we were unable to inhibit ATP-mediated 
vasodilatation more than ~20–30% (Crecelius 
et al. 2011). We were left to consider the 




Upon closer examination of the literature from 
animal models and isolated vessel 
preparations, we began to appreciate that 
non-NO, non-PG mechanisms of 
vasodilatation were likely to be critical for 
vascular control at rest and in response to 
stimulation. However, similar to the original 
unknown nature of NO and generalized name 
of EDRF, these pathways were not well 
described and generally termed endothelial-
derived hyperpolarizing factors (EDHFs); a 
response dependent on the endothelium that 
caused a characteristic hyperpolarization 
(decrease in membrane potential) of 
endothelial and vascular smooth muscle cells 
leading to vasodilatation (Feletou & Vanhoutte, 
2007). One hypothesis proposed potassium 
(K+) could be an EDHF given its potential 
release from endothelial cells and ability to 
stimulate the Na+/K+-ATPase pump and 
inwardly rectifying potassium channels (KIR) on 
vascular smooth muscles causing membrane 
potential hyperpolarization and vasorelaxation 
(Edwards et al. 1998). An important aspect of 
the proposed mechanism for K+ was its efflux 
through calcium-activated K+ channels (KCa). 
Taken together with data that demonstrated 
inhibition of small- and intermediate-
conductance KCa channels essentially abolished 
vasodilatation to luminal ATP application in the 
rat mesentery (Edwards et al. 1998), we had 
even more motivation to try and address 
hyperpolarizing mechanisms of vasodilatation 
in our human model as it might lend insight to 
our previous findings regarding ATP.
To date, investigators interested in inhibiting 
vascular hyperpolarization in humans were 
somewhat limited in the pharmacology that 
could be safely administered to do so. The 
toxins and venoms often used in isolated vessel 
preparations to inhibit small- and 
intermediated-conductance KCa channels posed 
safety risks. Enzymatic inhibition of specific 
proposed stimuli of hyperpolarization (e.g. 
cytochrome p450, H2O2, etc.) left readers 
questioning efficacy since directly challenging 
these inhibitors was difficult. We were excited 
to find that barium chloride (BaCl2) and ouabain 
could be given intra-arterially in low doses to 
inhibit KIR channels and Na+/K+-ATPase, 
respectively (Dawes et al. 2002). Importantly, 
low doses of KCl could be given intra-brachially 
to cause hyperpolarization and directly 
challenge inhibitor efficacy (Fig. 2). We saw an 
exciting opportunity to try and translate the 
isolated vessel experiments that supported a 
role for hyperpolarization in ATP-mediated 
vasodilatation (Winter & Dora, 2007) by 
inhibiting downstream mechanisms of VSMC 
hyperpolarization (Edwards et al. 1998).
“It is often challenging 
to translate mechanistic 
findings from animal 
models and in vitro 
studies to our human 
model, given our 
concerns for human 
safety.”
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Figure 4. Older adults fail to increase plasma [ATP] during handgrip exercise. Young (dark bars; 18–35 years) and older (light 
bars; 60–85 years) healthy individuals performed rhythmic handgrip exercise for 5 min at each increasing intensity (percent of 
individual maximal voluntary contraction (MVC)). Forearm blood flow (FBF) was measured and venous plasma [ATP] was 
determined via luciferin–luciferase assay of samples obtained from a retrograde antecubital catheter in the exercising arm. A, 
FBF was attenuated in older adults at 15% and 25% MVC. B, young individuals significantly increased [ATP]v at all exercise 
intensities, whereas older individuals failed to increase [ATP]v during exercise. At all intensities, [ATP]v was lower in older 
individuals than the young adults. *P < 0.05 vs. rest; †P < 0.05 vs. young adults. ‡P < 0.05 vs. 5% and 15% MVC within young 
adults. FFM, fat-free mass. Modified from Kirby et al. (2012).
Figure 5. Relationship of ATP, ageing and the regulation of vascular tone during exercise in humans. Exercise stimulates significant 
local vasodilatation and at sufficient intensity can activate the sympathetic nervous system to cause sympathetic 
vasoconstriction. The blunting of sympathetically mediated vasoconstriction that occurs in active skeletal muscle during exercise 
is known as ‘functional sympatholysis’. Older individuals display attenuated exercise vasodilatation and impaired functional 
sympatholysis (Dinenno et al. 2005; Kirby et al. 2011), yet the underlying mechanisms are not well understood. We have recently 
shown that ATP signals vasodilatation (1) primarily through KIR channel activation (Crecelius et al. 2012) and unlike other 
exogenous vasodilators, ATP is capable of modulating sympathetic vasoconstriction (2) and this occurs in a graded fashion, similar 
to during exercise (Kirby et al. 2008). Interestingly, the dilatory responsiveness to ATP (1) as well as the sympatholytic ability of 
this purine (2) is preserved in older individuals. Exercise elicits significant increases in venous plasma [ATP] in young individuals (3); 
however, this does not occur in older adults (Kirby et al. 2012). Thus, we propose impaired functional sympatholysis in this 




It was necessary to first establish our ability to 
sufficiently inhibit a hyperpolarizing stimulus 
(exogenous KCl) with the combination of BaCl2 
and ouabain, as had previously been described 
(Dawes et al. 2002). With these control 
experiments completed (in fairly profound 
fashion as we essentially eliminated any 
K+-mediated vasodilatation), we began our 
first experiments to test the impact of 
inhibition of KIR channels and Na+/K+-ATPase 
on ATP-mediated vasodilatation (Crecelius et 
al. 2012). These first studies were some of 
the more exciting in the laboratory to date. 
Given our data are collected in real-time, we 
were able to immediately estimate the changes 
in muscle blood flow following inhibition. From 
the first subject forward, it was clear these 
inhibitors were more ‘powerful’ than those we 
had used before and a large portion of 
ATP-mediated vasodilatation was explained by 
these pathways. After a number of experimental 
approaches, we determined the primary 
mechanism of ATP-mediated vasodilatation is 
vascular hyperpolarization via activation of KIR 
channels (Fig. 3) (Crecelius et al. 2012).
Putting it all together
As we were working to understand the basic 
signalling mechanisms of ATP, we were 
concurrently studying the potential role for 
ATP in the control of vascular tone during 
exercise in young and older adults, given the 
finding in young subjects that in sufficient 
concentration, it was sympatholytic 
(Rosenmeier et al. 2004; Kirby et al. 2008). 
Interestingly, although not completely 
surprising given our emerging overall working 
hypothesis, we demonstrated ATP was capable 
of blunting direct sympathetically mediated 
vasoconstriction in older individuals, despite 
these individuals having impaired exercise-
induced functional sympatholysis (Kirby et al. 
2011). Had we dissociated ATP and 
sympatholysis with these findings? Or, was it 
possible ATP retained the same vascular 
signalling capabilities in older adults, but this 
population failed to increase ATP during exercise 
to the same concentration as young individuals? 
We had begun to make plasma measures of 
ATP in the laboratory and pursued this 
hypothesis to tie our multiple studies together. 
This time, our ageing hypothesis was ‘correct’ 
as we showed older individuals failed to 
increase plasma ATP during incremental 
handgrip exercise in contrast to the significant 
increase observed in younger individuals (Fig. 
4) (Kirby et al. 2012). Thus, while we 
admittedly have not been able to directly 
inhibit the purinergic receptors to which ATP 
binds, as no pharmacology has been established 
that is capable of doing so, our findings of the 
mechanisms for ATP-mediated vasodilatation 
and our ageing data continue to support our 
overall hypothesis regarding a role for ATP in 
muscle blood flow regulation during exercise 
(Fig. 5).
Along the way
The ability to inhibit KIR channels and Na+/
K+-ATPase has provided the laboratory with a 
powerful pharmacological tool that we 
continue to use to address a number of 
hypotheses. Armstrong and colleagues had 
demonstrated a role of K+-mediated 
vasodilatation in rapid vasodilatation following 
a single muscle contraction in the hamster 
“In truth, we were quite 
sceptical of these 
intriguing findings, and 
thus we designed a 
study in the forearm to 
confirm ATP was 




Figure 6. Reactive hyperaemia occurs via activation of KIR channels and Na+/K+-ATPase. In young healthy humans, inhibition of KIR 
channels via barium chloride (BaCl2) significantly attenuates both the peak (A) and total (area under 150 s curve) (B) reactive 
hyperaemia (RH) following 5 min of forearm ischaemia (via upper arm cuff arterial occlusion). Inhibition of Na+/K+-ATPase via 
ouabain has no impact on peak RH (A) whereas results in a significant attenuation of total RH (B) and when combined with BaCl2, 
nearly abolishes the response. Data are means ± SEM for 8 and 16 subjects (BaCl2 or ouabain and BaCl2+ouabain, respectively). *P 
< 0.05 vs. zero; †P < 0.05 vs. BaCl2. ‡P < 0.05 vs. ouabain. Modified from Crecelius et al. (2013b).
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cremaster (Armstrong et al. 2007) using BaCl2 
and ouabain along with a pharmacological 
inhibitor of K+ efflux from skeletal muscle. 
Given our interest in rapid vasodilatation and 
the minimal number of mechanistic studies on 
the topic (Kirby et al. 2007), attempting to 
translate the findings of Armstrong and 
colleagues seemed prudent. In general, in line 
with the findings in the animal model, we 
demonstrated a significant role for K+ in 
mediating a portion of rapid vasodilatation in 
response to a single muscle contraction at a 
variety of intensities (Crecelius et al. 2013a).
Of perhaps greater clinical relevance, we 
recently determined whether reactive 
hyperaemia (RH), the large increase in blood 
flow following release of temporary ischaemia 
of skeletal muscle, was mediated by KIR 
channels and Na+/K+-ATPase. Although RH is a 
useful test of microvascular function and has 
clinical value in assessing risk of cardiovascular 
health (Anderson et al. 2011), prior to our 
work the underlying signalling mechanisms 
were largely undetermined. Impressively, nearly 
all (~90%) of the total (area under the curve) 
RH can be explained by combined activation of 
KIR channels and Na+/K+-ATPase and ~50% of 
the peak response is due to KIR channel 
activation (Fig. 6) (Crecelius et al. 2013b). This 
magnitude of inhibition is by far the most 
profound that has been observed to date.
Moving forward
We continue to pursue our ideas regarding 
muscle blood flow regulation, specifically 
during exercise and the unique role ATP may 
have in modulating sympathetic 
vasoconstriction. It is often challenging to 
translate mechanistic findings from animal 
models and in vitro studies to our human 
model, given our concerns for human safety. 
Part of what we find inspiring from this story is 
the integration of physiology and experimental 
approaches that was required to reach the 
point we find ourselves at. We drew from 
findings in older individuals to guide our basic 
science studies as well as applying our findings 
from young healthy humans to older 
individuals. While we probably would not have 
pursued many of these ideas without the initial 
findings and discoveries related to NO, we have 
developed a cautious attitude towards 
‘endothelial function’ as we have seen 
first-hand this monolayer is far more involved 
in vascular regulation than simply being a 
source of NO. Similarly, mechanistic studies in 
vitro and in animal models continue to 
stimulate ideas and provide rationale; yet, we 
observe important differences when 
translating some of these approaches to 
humans. Importantly, we acknowledge that 
scepticism, negative findings and unsupported 
hypotheses have provided us important 
directions we have excitedly followed.
